Daskal Ilan
- SEC CIK
- 0001446964
In the past year, 2 open-market sale filings worth $5.02M and no purchases.
Current role at each company
- VIAV Viavi Solutions Inc.EVP, CFOas of Sep 23, 2026
- BIO Bio-Rad Laboratories, Inc.EVP, Chief Financial Officeras of Sep 6, 2023
- NTUS Natus Medical IncDirectoras of Jul 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.02M
- 2 filings
- Net
- −$5.02M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Daskal Ilan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VIAV Viavi Solutions Inc.
EVP, CFO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 (view filing) | Jun 4 | 2 days | Daskal IlanEVP, CFO | SSale | −82.1K | $9.28 | −$761.8K | −100.0%0 after | |
| Dec 3, 2025 (view filing) | Dec 2 | 1 day | Daskal IlanEVP, CFO | SSale | −170.0K | $17.49 | −$2.97M | −94.4%10.1K after | 3 lots |
| Aug 31, 2026 (view filing)2:16 PM ET | Aug 31 | Same day | Daskal IlanEVP, CFO | SSale | −56.3K | $36.29 | −$2.04M | −84.7%10.1K after | 2 lots |
BIO Bio-Rad Laboratories, Inc.
EVP, Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 (view filing) | Aug 4 | 1 day | Daskal IlanEVP, Chief Financial Officer | SSaleBio-Rad A Common Stock | −2.30K | $751.84 | −$1.73M | −99.7%7 after | 3 lots |
| Sep 3, 2021 (view filing) | Sep 2 | 1 day | Daskal IlanEVP, Chief Financial Officer | SSaleBio-Rad A Common Stock | −540 | $828.00 | −$447.1K | −98.7%7 after | 2 lots |
| Sep 8, 2021 (view filing) | Sep 3 | 5 days | Daskal IlanEVP, Chief Financial Officer | SSaleBio-Rad A Common Stock | −270 | $820.06 | −$221.4K | −96.8%9 after |